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Identification, molecular characterization, and experimental
transmission of a new hemoplasma isolate from a cat with
hemolytic anemia in Switzerland
Abstract
Recently, there has been a growing interest in hemotropic mycoplasmal species (also known as the
hemoplasmas), the causative agents of infectious anemia in several mammalian species. In felids, two
different hemoplasma species have been recognized: Mycoplasma haemofelis (formerly
Haemobartonella felis) and "Candidatus Mycoplasma haemominutum." Recently developed molecular
methods have allowed sensitive and specific identification and quantification of these agents in feline
blood samples. In applying these methods to an epidemiological study surveying the Swiss pet cat
population for hemoplasma infection, we discovered a third novel and unique feline hemoplasma isolate
in a blood sample collected from a cat that had exhibited clinical signs of severe hemolytic anemia. This
agent was readily transmitted via intravenous inoculation to two specific-pathogen-free cats. One of
these cats was immunocompromised by the administration of methylprednisolone acetate prior to
inoculation, and this cat developed severe anemia. The other immunocompetent cat showed a moderate
decrease in packed cell volume. Additionally, an increase in red blood cell osmotic fragility was
observed. Sequencing of the entire 16S rRNA gene of the new hemoplasma isolate and phylogenetic
analysis showed that the isolate was most closely related to two rodent hemotropic mycoplasmal
species, M. coccoides and M. haemomuris. A quantitative real-time PCR assay specific for this newly
discovered agent was developed, which will be a prerequisite for the diagnosis of infections with the
new hemoplasma isolate.
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Recently, there has been a growing interest in hemotropic mycoplasmal species (also known as the hemo-
plasmas), the causative agents of infectious anemia in several mammalian species. In felids, two different
hemoplasma species have been recognized: Mycoplasma haemofelis (formerly Haemobartonella felis) and “Can-
didatus Mycoplasma haemominutum.” Recently developed molecular methods have allowed sensitive and
specific identification and quantification of these agents in feline blood samples. In applying these methods to
an epidemiological study surveying the Swiss pet cat population for hemoplasma infection, we discovered a
third novel and unique feline hemoplasma isolate in a blood sample collected from a cat that had exhibited
clinical signs of severe hemolytic anemia. This agent was readily transmitted via intravenous inoculation to two
specific-pathogen-free cats. One of these cats was immunocompromised by the administration of methylpred-
nisolone acetate prior to inoculation, and this cat developed severe anemia. The other immunocompetent cat
showed a moderate decrease in packed cell volume. Additionally, an increase in red blood cell osmotic fragility
was observed. Sequencing of the entire 16S rRNA gene of the new hemoplasma isolate and phylogenetic
analysis showed that the isolate was most closely related to two rodent hemotropic mycoplasmal species, M.
coccoides and M. haemomuris. A quantitative real-time PCR assay specific for this newly discovered agent was
developed, which will be a prerequisite for the diagnosis of infections with the new hemoplasma isolate.
Haemobartonella felis, the causative agent of feline infectious
anemia, was recently reclassified within a newly defined group
of hemotropic mycoplasmal species (also known as the hemo-
plasmas). Sequencing of the 16S rRNA genes of different fe-
line isolates has resulted in the recognition of two different
species, Mycoplasma haemofelis and “Candidatus Mycoplasma
haemominutum” (1, 10, 11, 20, 24, 26, 28), which parasitize
feline red blood cells (RBC). Experimental infection studies
have shown that the two species differ in terms of pathogenicity
(10, 36): cats experimentally infected with “Candidatus Myco-
plasma haemominutum” exhibit minimal clinical signs and
anemia is not usually induced, while M. haemofelis infection
often results in severe hemolytic anemia. Since M. haemofelis
and “Candidatus Mycoplasma haemominutum” cannot be cul-
tured in vitro, diagnosis until recently has relied upon cytolog-
ical identification on blood smears (4). However, the develop-
ment of new molecular methods have facilitated the sensitive
and specific identification and quantification of these agents (1,
19, 31), and PCR analysis is now the diagnostic method of
choice for hemoplasma infections.
There is still little knowledge of the epidemiology of these
agents. Both species have been shown to exhibit worldwide
geographical distribution (6, 8, 19, 29, 30, 35), and isolates
from three different continents have shown near sequence
identities (32). We now unexpectedly identified a third hemo-
plasma agent in a cat with a clinical history of severe hemolytic
anemia. The aim of this study was to characterize the clinical
and molecular nature of this new isolate.
(These studies were conducted by B. Willi as partial fulfill-
ment of the requirements for a Ph.D. degree at the Vetsuisse
Faculty, University of Zurich, Zurich, Switzerland.)
MATERIALS AND METHODS
Animals and experimental design of the transmission experiment. The new
isolate was discovered in cat 946, a 13-year-old male castrated cat presented to
the Clinic for Small Animal Internal Medicine, University of Zurich, in Decem-
ber 2002. For the transmission experiment, two 10-year-old specific-pathogen-
free male castrated cats, cat 1 and cat 2, were used; both were confirmed to be
free from feline hemoplasmas (19, 31). The blood types of the three cats were
tested for compatibility using a RapidVet-H feline test (Medical Solution Gmbh,
Steinhausen, Switzerland). Fresh heparinized blood from cat 946 for inoculation
was not available until 10 months after the acute phase of illness, when 4 ml was
intravenously inoculated into cat 1. This animal had received methylprednisolone
acetate (10 mg/kg of body weight, intramuscularly) two and one weeks before
inoculation to increase the probability of transmission. Cat 2 was inoculated
intravenously with 4 ml of heparinized blood freshly collected from cat 1 at post-
infection (p.i.) day 35. Blood samples from cats 1 and 2 were collected regularly
(for time points, see Fig. 1), and the cats were monitored for body temperature,
heart rate, respiratory rate, mucous membrane color, attitude, and appetite.
Hematology and biochemistry. Complete hemograms were performed using a
Cell-Dyn 3500 instrument (Abbott, Baar, Switzerland). Giemsa-stained blood
smears were made from fresh EDTA-anticoagulated blood. Aggregate reticulo-
cytes were counted after methylene blue staining. Serum biochemistry was per-
formed using a Cobas Integra 700 instrument (Roche Diagnostics, Rotkreuz,
Switzerland). Reference ranges are stated as 5% and 95% quantiles.
Osmotic fragility and direct Coombs testing. RBC osmotic fragility (OF) was
measured by adding 50 l of freshly collected EDTA-anticoagulated blood to 5
ml of 0.3%-to-0.9% NaCl solutions. After a 1-h incubation at 37°C, samples were
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suisse-Faculty, University of Zurich, Winterthurerstrasse 260, 8057
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centrifuged (600  g, 10 min), and the hemoglobin content of the supernatant
was determined spectrophotometrically at 546 nm. Reference values were de-
termined using nine healthy cats. For direct Coombs testing, erythrocytes from
EDTA-anticoagulated blood samples were washed three times with phosphate-
buffered saline, and 100 l of washed RBC were diluted in 4.9 ml 0.9% NaCl
solution. A 25-l aliquot of the RBC suspension was then incubated at 37°C for
1 h with feline antiglobulin reagent (ICN Biomedicals Inc., Eschewege, Ger-
many) in dilutions ranging from 1:2 to 1:2,560 and evaluated for agglutination.
Agglutination in dilutions of 1:8 was reported as negative.
DNA extraction and diagnostic PCR assays. DNA was purified from 200 l
EDTA-anticoagulated blood using a MagNaPure LC DNA Isolation Kit I
(Roche Diagnostics). PCR assays for the detection of M. haemofelis, “Candidatus
Mycoplasma haemominutum,” feline coronavirus, feline immunodeficiency vi-
rus, feline leukemia virus (FeLV), and feline parvovirus were performed as
previously reported (14, 17, 19, 21, 23, 31).
Sequencing of the 16S rRNA gene of the new isolate. The 16S rRNA gene of
the new hemoplasma isolate in cat 1 was amplified using universal primers fHf1
and rHf2 (24) in a 25-l reaction mixture containing 2.5 l of 10 PCR buffer
(Sigma-Aldrich, Buchs, Switzerland), an 800 nM concentration of each primer, a
200 M concentration of each dNTP (Sigma-Aldrich), 2.5 mM MgSO4, 0.8 U Pfu
DNA polymerase (Promega Corporation, Catalys AG, Wallisellen, Switzerland),
and 5 l template DNA. The thermal program comprised 95°C for 1.5 min; 35
cycles of 95°C for 1 min, 51 to 61°C for 30 s, and 72°C for 3 min; and finally, 72°C
for 10 min. PCR products of 1,440 bp were purified from a 1.2% agarose gel with
a MinElute gel extraction kit (QIAGEN, Hombrechtikon, Switzerland) and
cloned using a Zero Blunt TOPO PCR cloning kit (Invitrogen, Basel, Switzer-
land). As a result of the lower hemoplasma loads in cats 2 and 946, species-
specific primers (forward: 5-GAA CTG TCC AAA AGG CAG TTA GC-3;
reverse: 5-AGA AGT TTC ATT CTT GAC ACA ATT GAA-3) were used to
amplify a 1,317-bp product of the 16S rRNA gene of the new isolate. The 25-l
reaction mixture contained 2.5 l of 10 PCR buffer (Applied Biosystems), an
800 nM concentration of each primer, a 200 M concentration of each dNTP
(Sigma-Aldrich), 1.5 mM MgCl2, and 1.25 U AmpliTaq Gold DNA polymerase
(Applied Biosystems), and 5 l of template DNA. The thermal program com-
prised 95°C for 5 min; 35 cycles of 95°C for 30 s, 51 to 61°C for 30 s, and 72°C
for 2 min; and finally, 72°C for 10 min. Products were cloned with a TOPO TA
cloning kit (Invitrogen), and plasmid DNA was purified with a QIAprep Spin
Miniprep kit (QIAGEN). Sequencing was performed with M13 forward and
reverse primers and an internal primer (5-GAA GGC CAG ACA GGT CGT
AAA G-3) using a BigDye Terminator cycle sequencing kit (Applied Biosys-
tems). Cycling conditions were as follows: 96°C for 1 min and 25 cycles of 96°C
for 10 s, 50°C for 5 s, and 60°C for 4 min. The products were purified with DyeEx
spin columns (QIAGEN) and analyzed on an ABI PRISM 310 genetic analyzer
(Applied Biosystems). For sequence comparison, GCG Wisconsin Package (Ac-
celrys GmbH, Munich, Germany) was used. The sequences were aligned using
CLUSTAL W (33).
Development of a real-time PCR specific for the new hemoplasma isolate. To
detect the new isolate, specific 16S rRNA forward (5-GAA GGC CAG ACA
GGT CGT AAA G-3) and reverse (5-CTG GCA CAT AGT TWG CTG TCA
CTT A-3) primers and a probe (6-carboxyfluorescein-AAA TTT GAT GGT
ACC CTC TGA-minor groove binder) were designed. The 25-l PCR mixture
comprised 12.5 l of 2 qPCR Mastermix (Eurogentec, Seraing, Belgium), 880
nM of each primer, 200 nM of probe, and 5 l of template DNA. Assays were
performed using an ABI PRISM 7700 sequence detection system (Applied
Biosystems). For absolute quantification, plasmids containing the cloned 16S
rRNA genes were generated. Purified DNA was digested with NotI and quan-
tified spectrophotometrically. The DNA template was serially diluted tenfold in
a solution of 30 g/ml of salmon sperm DNA (Invitrogen), aliquoted, and stored
at 20°C until use.
Statistical analysis. For correlation analyses, the Spearman rank correlation
test was used (3). A Wilcoxon signed-rank test was performed to compare the
hemoplasma loads of cats 1 and 2 (3).
Nucleotide sequence accession number. The nucleotide sequence of the 16S
rRNA gene of the new isolate has been submitted to GenBank (accession
number AY831867).
RESULTS
Identification of a new hemoplasma isolate. During an epi-
demiological study to assess the prevalence of hemoplasma
infections in Swiss cats, cat 946 yielded discrepant PCR results.
DNA extracted from a blood sample from this cat collected in
March 2003 tested positive by conventional (19) but negative
by real-time PCR specific for M. haemofelis and “Candidatus
Mycoplasma haemominutum” (31). Four months prior to pre-
sentation, cat 946 had exhibited clinical signs consistent with
haemobartonellosis, including lethargy, anorexia, pallor, dys-
pnea, and weight loss. Examination of blood and urine samples
collected at that time revealed signs of intravascular hemolysis
with a packed cell volume (PCV) of 12% (reference value,
33% to 45%), leukocytosis (25.6  109/liter; reference value,
5  109 to 18.9  109/liter), hyperbilirubinemia (34 mol/liter;
reference value, 0 to 15 mol/liter), and hemoglobinuria. The
anemia became highly regenerative 4 days after first presenta-
tion (PCV, 17%; aggregated reticulocyte counts of 201,670/l;
regeneration defined by a count of 60,000/l). A primary
immune-mediated hemolytic anemia was suspected, and the
cat was treated with corticosteroids. This treatment was asso-
ciated with only a transient improvement in the cat’s clinical
status. After definitive diagnosis of hemoplasma infection and
after blood had been collected for the transmission experi-
ment, cat 946 was treated with oral doxycycline (10 mg/kg/day
for 14 days), and its clinical condition improved. RBC OF was
increased in samples collected between 12 and 21 months after
acute illness (50% hemolysis in 0.68% to 0.75% NaCl; refer-
ence range, 0.50% to 0.57% NaCl).
Transmission experiment. To gain a first insight into the
new hemoplasma’s pathogenic potential, a transmission exper-
iment was conducted. The blood samples collected for trans-
mission tested negative for FeLV, feline immunodeficiency
virus, feline coronavirus, and feline parvovirus infection. The
inoculum received by cat 1 contained a total of 3.8 103 copies
of the new hemoplasma isolate. Cat 1 became PCR positive 8
days p.i. and remained positive for 88 days (Fig. 1). It devel-
oped anemia, with a drop in PCV from 34% to 17% by day
FIG. 1. Transmission experiment. The charts depict the loads of
the newly described isolate (log copy number of DNA template per ml
of blood, left y axes, black triangles) and the courses of PCV (%, right
y axes, open squares) in cat 1 (A) and cat 2 (B) over 100 days p.i.
(x axes). The reference ranges of PCV are shaded grey. The lower
detection limits of the real-time PCR assay (100 copies/ml blood) are
indicated by dotted lines.
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9 p.i. (Fig. 1). Mild clinical signs of pallor and lethargy were
observed, from which the cat recovered without treatment; the
PCV remained below the reference range until day 80 p.i. (Fig.
1). The hemoplasma load was inversely correlated with PCV
(r  0.79; P  0.0001), with a maximal load of 1.9  107
copies/ml blood on day 18 p.i. (Fig. 1). RBC OF was measured
starting at day 36 p.i. (50% hemolysis in 0.57% NaCl); there-
after, it decreased continuously until day 135 p.i. (50% hemo-
lysis in 0.52% NaCl) and stayed at this value until the end of
measurement (day 170 p.i.).
The blood sample used to inoculate cat 2 contained a total
of 1.6  104 copies of the new isolate. Cat 2 became PCR
positive 11 days p.i. and stayed positive for 80 days (Fig. 1). The
cat developed a mild anemia with a drop in PCV from 34% to
26% by 20 days p.i. (Fig. 1). No clinical signs were observed.
The hemoplasma load was inversely correlated with PCV (r 
0.65; P  0.0002) but was lower than that of cat 1 (P 
0.0085; values of 15 time points were compared) and reached
a maximum of 2.8 105 copies/ml blood on day 16 p.i. (Fig. 1).
The RBC OF of cat 2 continuously increased over the first 31
days p.i. (Fig. 2) and returned to normal values 59 days p.i.
(50% hemolysis in 0.54% NaCl). The OF was correlated with
the hemoplasma load in this animal (r  0.63; P  0.012;
values of 15 time points were compared). All blood samples
collected from cats 1 and 2 (n  6 for each cat) tested negative
in direct Coombs testing.
Molecular characterization of the new isolate. Comparison
of the 16S rRNA gene sequences obtained from the blood of
cats 1, 2, and 946 with those held in GenBank revealed the
following similarities (in descending order): M. coccoides
(92%), M. haemomuris (90%), M. haemofelis (88%), M. hae-
mocanis (88%), M. haemolama (83%), M. wenyonii (83%),
“Candidatus Mycoplasma kahanei” (83%), “Candidatus Myco-
plasma haemominutum” (83%), M. ovis (83%), “Candidatus
Mycoplasma haemoparvum” (82%), M. suis (82%), M. fastid-
iosum (82%), and “Candidatus Mycoplasma haemodidelphi-
dis” (81%).
Construction of a phylogenetic tree confirmed the close re-
lationship of the newly described feline hemoplasma isolate
with M. coccoides and M. haemomuris, whereas M. haemofelis
was clearly less closely related, and “Candidatus Mycoplasma
haemominutum” was only distantly related (Fig. 3).
DISCUSSION
A new hemoplasma isolate was identified in a naturally in-
fected cat that had exhibited clinical signs of severe intra-
vascular hemolytic anemia. The newly discovered agent also
induced anemia in two experimentally infected cats, and de-
creased PCV was associated with high hemoplasma loads. One
of the cats had been immunocompromised with methylpred-
nisolone acetate. This corticosteroid alone is not known to
cause a decrease in PCV but, in contrast, has been used to treat
aplastic and immune-mediated hemolytic anemia due to its
ability to increase the half-lives of RBC by decreasing their
splenic removal (27).
The two experimentally infected animals showed mild or no
clinical signs, whereas the naturally infected animal developed
severe illness. Hemoplasma organisms are often opportunistic
in their disease potentials, and the presence of parasites or
other infectious agents not readily recognized could have wors-
ened the clinical outcome for cat 946. Immunosuppressive
FIG. 2. Course of RBC OF in cat 2 over 31 days after experimental
infection with the newly described isolate. The absorbance measured
after incubation in 0.3% NaCl solution was defined as 100% hemolysis;
the absorbance measured in 0.9% NaCl solution was defined as 0%
hemolysis. The curves were fitted to the data using sigmoid regression
(SigmaPlot Regression Wizard, SSPS, Chicago, Illinois). The shift in
RBC OF from days 0 to 31 p.i. is indicated by an arrow. The complete
time courses of the OF cannot be given for cats 1 and 946 because this
assay had not been established during their early infection periods.
FIG. 3. Phylogenetic tree demonstrating the relationship of the
new isolate to other hemoplasma species using a neighbor joining
method. M. coccoides (AY171918), M. haemomuris (U82963), M. hae-
mocanis (AY150973), M. haemofelis (AY150985), M. fastidiosum
(AF125878), “Candidatus Mycoplasma haemominutum” (AY297712),
“Candidatus Mycoplasma kahanei” (AF338269), “Candidatus Myco-
plasma haemoparvum” (AY532390), M. wenyonii (AF016546), and
M. suis (AY492086) are shown. The numbers at the nodes were gene-
rated from 1,000 bootstrap resamplings; values of500 are not shown.
The bar represents the mean number of differences per 100 sites.
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agents such as FeLV have been shown to influence the clinical
courses of hemoplasma infections (5, 12, 15). The three cats of
the present study were free of retroviral infections. However,
the lack of an adequate immune response due to iatrogenic
immunosuppression in cat 1 could explain why this animal
developed a more severe outcome of infection, despite being
given a lower dose of hemoplasma organisms, than cat 2. An
inadequate immune response could also explain the higher
hemoplasma loads detected in cat 1 compared to cat 2, which
in turn would further underline the importance of the immune
response during hemoplasma infections. Additionally, the cat-
to-cat passage of the new isolate, although unexpected, could
have led to a decreased pathogenic potential of the agent, as
recently reported for “Candidatus Mycoplasma haemominu-
tum” (12). Cat 2 was infected with cat-passaged material which
could also have contributed to the lower hemoplasma load and
the milder course of infection observed in this cat.
Cat 946 in the present study was a 13-year-old male cas-
trated animal, and cats 1 and 2 in the transmission experiment
were also old male castrated animals. Increasing age and male
sex have been reported as factors predisposing for feline
hemoplasma infections (13, 16, 25, 29). It is possible that the
older male status of the cats in the present study influenced the
outcome of the infection with the new hemoplasma isolate.
The mechanisms by which feline hemoplasmas, especially
M. haemofelis, induce acute hemolysis in infected cats are not
well understood. Maede and Hata (22) claimed a central role
for the spleen in sequestrating parasitized RBC and removing
attached organisms from the RBC surface. They reported an
increase in RBC OF following the first appearance of hemo-
plasma organisms on the RBC surfaces. Increased RBC OF
was also observed in the present study for cats 2 and 946, being
most severe in the naturally infected cat 946, which developed
the most severe clinical signs. Interestingly, the RBC OF was
chronically increased in the latter cat, whereas it returned to
normal values in cat 2. In the above-mentioned study (22), cats
that had exhibited chronic increased RBC OF also tested per-
sistently positive in direct Coombs testing. Different authors
have reported that secondary immunologic responses to eryth-
rocytic antigens are associated with hemoplasma infections
(7, 22, 37). Direct Coombs testing was not performed in the
clinically ill cat. In the two experimentally infected animals,
Coombs testing yielded negative results with several blood
samples collected throughout the transmission experiment.
However, the moderate and transient increase in RBC OF in
cat 2 could still be explained by direct RBC damage by the
hemoplasma organisms themselves; RBC OF was directly cor-
related with the hemoplasma load in cat 2, and 1 week after the
organisms became undetectable by PCR, the OF returned to
reference values.
Phylogenetic analysis of the 16S rRNA gene of the novel
hemoplasma isolate surprisingly revealed a close relationship
to M. coccoides, a hemoplasma species isolated from rodents.
M. coccoides is known to induce hemolytic anemia in mice and
rats (7, 18, 34). M. coccoides has been shown to be mechani-
cally transmitted between mice through the mouse louse Poly-
plax serrata (2). Experimental transmission of feline hemoplas-
ma species between cats by oral inoculation of infected blood
has been successful (9). In view of the permanent outdoor ac-
cess and successful mousing reported for cat 946, one could
speculate that if this new hemoplasma isolate is present in wild
rodents in Switzerland, an interspecies transmission from
mouse to cat could have taken place through hunting.
So far, 3 out of 250 feline blood samples from Swiss pet cats
have tested positive for the newly described hemoplasma iso-
late using the specific real-time PCR assay (B. Willi, unpub-
lished data). These preliminary data indicate that this agent is
of general relevance. In none of these infected cats have char-
acteristic hemoplasma-like inclusions been doubtlessly identi-
fied on the blood smears. This could be due to the rather low
hemoplasma loads measured in all of the assayed blood sam-
ples, compared to the loads previously reported in hemo-
plasma-infected cats with conclusively positive blood smears
(31). The authors therefore recommend that the herein-de-
scribed real-time PCR assay be used to accurately diagnose
infections with the new hemoplasma isolate in felids.
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